Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2000 | 03-2000 | 12-1999 | 09-1999 | 06-1999 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,511,700 | 845,500 | 2,721,000 | 1,934,700 | 1,202,100 |
| Depreciation Amortization | 237,400 | 116,200 | 439,700 | 340,400 | 224,400 |
| Income taxes - deferred | 87,700 | -14,400 | N/A | N/A | N/A |
| Other Working Capital | -182,800 | -91,800 | -425,800 | -741,000 | -699,500 |
| Other Operating Activity | -198,700 | -245,300 | -115,200 | 14,600 | -119,900 |
| Operating Cash Flow | $1,455,300 | $610,200 | $2,619,700 | $1,548,700 | $607,100 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -276,000 | -110,000 | -450,000 | -320,200 | -194,000 |
| Net Acquisitions | N/A | N/A | 1,600,000 | 1,568,200 | 1,578,200 |
| Purchase Of Investment | -726,800 | -139,700 | N/A | N/A | N/A |
| Sale Of Investment | 497,500 | 452,200 | N/A | N/A | N/A |
| Other Investing Activity | -66,100 | -22,900 | -63,300 | 29,200 | -700 |
| Investing Cash Flow | $-571,400 | $179,600 | $1,086,700 | $1,277,200 | $1,383,500 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -186,800 | -188,400 | N/A | N/A | N/A |
| Debt Issued | -14,000 | -6,000 | N/A | N/A | N/A |
| Common Stock Issued | 76,400 | 44,700 | N/A | N/A | N/A |
| Common Stock Repurchased | -502,400 | -241,800 | N/A | N/A | N/A |
| Dividend Paid | -563,300 | -282,200 | -1,000,500 | -751,500 | -502,200 |
| Other Financing Activity | 0 | 0 | -452,200 | -243,400 | -911,100 |
| Financing Cash Flow | $-1,190,100 | $-673,700 | $-1,452,700 | $-994,900 | $-1,413,300 |
| Exchange Rate Effect | -23,700 | -18,700 | -49,000 | -34,800 | -41,300 |
| Beginning Cash Position | 3,700,400 | 3,700,400 | 1,495,700 | 1,495,700 | 1,495,700 |
| End Cash Position | 3,370,500 | 3,797,800 | 3,700,400 | 3,291,900 | 2,031,700 |
| Net Cash Flow | $-329,900 | $97,400 | $2,204,700 | $1,796,200 | $536,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,455,300 | 610,200 | 2,619,700 | 1,548,700 | 607,100 |
| Capital Expenditure | -276,000 | -110,000 | N/A | N/A | N/A |
| Free Cash Flow | 1,179,300 | 500,200 | 2,619,700 | 1,548,700 | 607,100 |